FDA Warning Letter — Jajco, Inc. DBA Anchor Drugs Pharmacy

Case 522517 — FEI 3012327563

The FDA took a Warning Letter action against Jajco, Inc. DBA Anchor Drugs Pharmacy on August 22, 2017 (South San Francisco, CA). The action was issued by CDER and concerns drugs products. This facility has 1 recent FDA inspection on record.

Action Details

Facility
Jajco, Inc. DBA Anchor Drugs Pharmacy
Date
August 22, 2017
Fiscal Year
2017
Product Type
Drugs
Center
CDER
Location
South San Francisco, CA (United States)